Vanda Pharmaceuticals (VNDA) Gross Margin (2010 - 2026)
Vanda Pharmaceuticals' Gross Margin was 92.95% in Q2 2026, down 1.84 percentage points from 94.80% a year earlier and down 0.94 percentage points from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Gross Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vanda Pharmaceuticals' Gross Margin was 93.74% through Jun 30, 2026, down 0.66 percentage points year-over-year; for FY2025, it was 93.96%, down 0.34 percentage points from FY2024.
- Gross Margin shows a five-year change of +3.38 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 94.31% in FY2024 (+1.99 pp), 92.32% in FY2023 (+1.86 pp), 90.45% in FY2022 (-0.01 pp) and 90.46% in FY2021 (-0.12 pp).
- The Q2 2026 figure marks the lowest quarterly Gross Margin since Q1 2024.
- Compared with a year earlier, Gross Margin was higher in six of the last eight quarters, with an average year-over-year change of +0.39 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q4 2024 (a gain of 2.77 percentage points); the worst was Q2 2026 (a drop of 1.84 percentage points).
- Per Business Quant data, VNDA's Gross Margin in the three quarters before Q2 2026 was 93.89% (Q1 2026), 93.30% (Q4 2025) and 94.75% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 72.78% |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | 92.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.95% |
| Mar 31, 2026 | 93.89% |
| Dec 31, 2025 | 93.30% |
| Sep 30, 2025 | 94.75% |
| Jun 30, 2025 | 94.80% |
| Mar 31, 2025 | 92.96% |
| Dec 31, 2024 | 95.13% |
| Sep 30, 2024 | 94.65% |
| Jun 30, 2024 | 94.59% |
| Mar 31, 2024 | 92.75% |
| Dec 31, 2023 | 92.36% |
| Sep 30, 2023 | 92.11% |
| Jun 30, 2023 | 92.40% |
| Mar 31, 2023 | 92.36% |
| Dec 31, 2022 | 90.33% |
| Sep 30, 2022 | 90.32% |
| Jun 30, 2022 | 90.59% |
| Mar 31, 2022 | 90.59% |
| Dec 31, 2021 | 90.83% |
| Sep 30, 2021 | 90.30% |
API Access
Vanda Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();